Bacterial resistance to antibiotics: Active efflux and reduced uptake

Advanced Drug Delivery Reviews

Volumn 57, Issue 10, 2005, Pages 1486-1513

  Kumar, Ayush ^a   Schweizer, Herbert P ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Active efflux; Outer membrane permeability; Porins; Regulation; RND pumps

Indexed keywords

BACTERIA; BIOLOGICAL MEMBRANES; MECHANICAL PERMEABILITY;

DRUG MOLECULES; GRAM-NEGATIVE BACTERIA; MEMBRANE PERMEABILITY; PATHOGENS;

ANTIBIOTICS;

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBENICILLIN; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COUMESTROL; ERYTHROMYCIN; FUSIDIC ACID; GRA 936; LEVOFLOXACIN; MACROLIDE; MC 207 110; MEROPENEM; MITOMYCIN; NOVOBIOCIN; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ROXITHROMYCIN; TETRACYCLINE; TIGECYCLINE; TRIMETHOPRIM; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACILLUS SUBTILIS; BACTERIAL STRAIN; CELL MEMBRANE PERMEABILITY; CRYSTAL STRUCTURE; DRUG TRANSPORT; ESCHERICHIA COLI; GENE FUNCTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MULTIDRUG RESISTANCE; NONHUMAN; OUTER MEMBRANE; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MODELS, BIOLOGICAL; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;

EID: 22144471145     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2005.04.004     Document Type: Review

References (293)

1. H.C. Neu The crisis in antibiotic resistance Science 257 1992 1064 1073
2. S.B. Levy Antibiotic resistance: an ecological imbalance Ciba Found. Symp. 207 1997 1 9
3. B.H. Normark, and S. Normark Evolution and spread of antibiotic resistance J. Intern. Med. 252 2002 91 106
4. R.L. Juliano, and V. Ling A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochim. Biophys. Acta 455 1976 152 162
5. P.R. Ball, I. Chopra, and S.J. Eccles Accumulation of tetracyclines by Escherichia coli K-12 Biochem. Biophys. Res. Commun. 77 1977 1500 1507
6. S.B. Levy, and L. McMurry Plasmid-determined tetracycline resistance involves new transport systems for tetracycline Nature 276 1978 90 92
7. P.R. Ball, S.W. Shales, and I. Chopra Plasmid-mediated tetracycline resistance in Escherichia coli involves increased efflux of the antibiotic Biochem. Biophys. Res. Commun. 93 1980 74 81
8. L. McMurry, R.E. Petrucci Jr., and S.B. Levy Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 77 1980 3974 3977
9. O. Lomovskaya, M.S. Warren, and V. Lee D. Hughes D.I. Andersson Antibiotic Development and Resistance 2001 Taylor and Francis London 65 90
10. K. Poole Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria Curr. Pharm. Biotechnol. 3 2002 77 98
11. K. Poole Efflux-mediated multiresistance in Gram-negative bacteria Clin. Microbiol. Infect. 10 2004 12 26
12. X.Z. Li, and H. Nikaido Efflux-mediated drug resistance in bacteria Drugs 64 2004 159 204
13. I.T. Paulsen, and K. Lewis Microbial Drug Efflux 2002 Horizon Press Wynmondham
14. H. Nikaido Molecular basis of bacterial outer membrane permeability revisited Microbiol. Mol. Biol. Rev. 67 2003 593 656
15. I.T. Paulsen, M.K. Sliwinski, and M.H. Saier Jr. Microbial genome analyses: global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities J. Mol. Biol. 277 1998 573 592
16. S.S. Pao, I.T. Paulsen, and M.H. Saier Jr. Major facilitator superfamily Microbiol. Mol. Biol. Rev. 62 1998 1 34
17. M.D. Marger, and M.H. Saier Jr. A major superfamily of transmembrane facilitators that catalyse uniport, symport and antiport Trends Biochem. Sci. 18 1993 13 20
18. H.W. van Veen, and W.N. Konings The ABC family of multidrug transporters in microorganisms Biochim. Biophys. Acta 1365 1998 31 36
19. I.T. Paulsen, R.A. Skurray, R. Tam, M.H. Saier, R.J. Turner, J.H. Weiner, E.B. Goldberg, and L.L. Grinius The SMR family: a novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs Mol. Microbiol. 19 1996 1167 1175
20. M.H. Saier Jr., R. Tam, A. Reizer, and J. Reizer Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport Mol. Microbiol. 11 1994 841 847
21. M.H. Brown, I.T. Paulsen, and R.A. Skurray The multidrug efflux protein NorM is a prototype of a new family of transporters Mol. Microbiol. 31 1999 393 395
22. P. Butaye, A. Cloeckaert, and S. Schwarz Mobile genes coding for efflux-mediated antimicrobial resistance in Gram-positive and Gram-negative bacteria Int. J. Antimicrob. Agents 22 2003 205 210
23. H. Yoshida, M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones J. Bacteriol. 172 1990 6942 6949
24. O. Lomovskaya, and K. Lewis Emr, an Escherichia coli locus for multidrug resistance Proc. Natl. Acad. Sci. U. S. A. 89 1992 8938 8942
25. J.M. Tennent, B.R. Lyon, M. Midgley, I.G. Jones, A.S. Purewal, and R.A. Skurray Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus J. Gen. Microbiol. 135 1989 1 10
26. I.T. Paulsen, M.H. Brown, T.G. Littlejohn, B.A. Mitchell, and R.A. Skurray Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity Proc. Natl. Acad. Sci. U. S. A. 93 1996 3630 3635
27. J. Clancy, J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A.V. Kamath, J. Bergeron, and J.A. Retsema Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes Mol. Microbiol. 22 1996 867 879
28. I. Chopra, and M. Roberts Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance Microbiol. Mol. Biol. Rev. 65 2001 232 260
29. C.F. Higgins ABC transporters: from microorganisms to man Annu. Rev. Cell Biol. 8 1992 67 113
30. M.J. Fath, and R. Kolter ABC transporters: bacterial exporters Microbiol. Rev. 57 1993 995 1017
31. H. Bolhuis, H.W. van Veen, J.R. Brands, M. Putman, B. Poolman, A.J. Driessen, and W.N. Konings Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP J. Biol. Chem. 271 1996 24123 24128
32. M.H. Saier Jr., and I.T. Paulsen Phylogeny of multidrug transporters Semin. Cell Dev. Biol. 12 2001 205 213
33. C. Ma, and G. Chang Structure of the multidrug resistance efflux transporter EmrE from Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 101 2004 2852 2857
34. L. Grinius, G. Dreguniene, E.B. Goldberg, C.-H. Liao, and S.J. Projan A staphylococcal multidrug resistance gene product is a member of a new protein family Plasmid 27 1992 119 129
35. S. Schuldiner, M. Lebendiker, and H. Yerushalmi EmrE, the smallest ion-coupled transporter, provides a unique paradigm for structure-function studies J. Exp. Biol. 200 1997 335 341
36. T.-T. Tseng, K.S. Gratwick, J. Kollman, D. Park, D.H. Nies, A. Goffeau, and M.H. Saier Jr. The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins J. Mol. Microbiol. Biotechnol. 1 1999 107 125
37. L.H. Hansen, E. Johannesen, M. Burmolle, A.H. Sorensen, and S.J. Sorensen Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli Antimicrob. Agents Chemother. 48 2004 3332 3337
38. D. Ma, D.N. Cook, M. Alberti, N.G. Pon, H. Nikaido, and J.E. Hearst Molecular cloning and characterization of acrA and acrE genes of Escherichia coli J. Bacteriol. 175 1993 6299 6313
39. D. Ma, D.N. Cook, M. Alberti, N.G. Pon, H. Nikaido, and J.E. Hearst Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli Mol. Microbiol. 16 1995 45 55
40. K. Poole, K. Krebes, C. McNally, and S. Neshat Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon J. Bacteriol. 175 1993 7363 7372
41. Y. Morita, K. Kodama, S. Shiota, T. Mine, A. Kataoka, T. Mizushima, and T. Tsuchiya NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli Antimicrob. Agents Chemother. 42 1998 1778 1782
42. C. Carbon MRSA and MRSE: is there an answer? Clin. Microbiol. Infect. 6 Suppl. 2 2000 17 22
43. A. Marchese, G.C. Schito, and E.A. Debbia Evolution of antibiotic resistance in gram-positive pathogens J. Chemother. 12 2000 459 462
44. T.G. Littlejohn, I.T. Paulsen, M.T. Gillespie, J.M. Tennent, M. Midgley, I.G. Jones, A.S. Purewal, and R.A. Skurray Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus FEMS Microbiol. Lett. 74 1992 259 265
45. K. Poole Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria Antimicrob. Agents Chemother. 44 2000 2595 2599
46. E.Y. Ng, M. Trucksis, and D.C. Hooper Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome Antimicrob. Agents Chemother. 38 1994 1345 1355
47. G.V. Doern, and S.D. Brown Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01 J. Infect. 48 2004 56 65
48. N.P. Brenwald, M.J. Gill, and R. Wise The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin J. Antimicrob. Chemother. 40 1997 458 460
49. K.J. Madaras-Kelly, C. Daniels, M. Hegbloom, and M. Thompson Pharmacodynamic characterization of efflux and topoisomerase IV-mediated fluoroquinolone resistance in Streptococcus pneumoniae J. Antimicrob. Chemother. 50 2002 211 218
50. M.J. Gill, N.P. Brenwald, and R. Wise Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae Antimicrob. Agents Chemother. 43 1999 187 189
51. A. Tait-Kamradt, J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutcliffe mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae Antimicrob. Agents Chemother. 41 1997 2251 2255
52. P. Zhong, and V.D. Shortridge The role of efflux in macrolide resistance Drug Resist. Updates 3 2000 325 329
53. M. Santagati, F. Iannelli, M.R. Oggioni, S. Stefani, and G. Pozzi Abstract Presented at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada 2000
54. A.A. Neyfakh The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein Antimicrob. Agents Chemother. 36 1992 484 485
55. M. Ahmed, L. Lyass, P.N. Markham, S.S. Taylor, N. Vazquez-Laslop, and A.A. Neyfakh Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated J. Bacteriol. 177 1995 3904 3910
56. A.A. Neyfakh The ostensible paradox of multidrug recognition J. Mol. Microbiol. Biotechnol. 3 2001 151 154
57. S. Miyamae, H. Nikaido, Y. Tanaka, and F. Yoshimura Active efflux of norfloxacin by Bacteroides fragilis Antimicrob. Agents Chemother. 42 1998 2119 2121
58. I.W. Nilsen, I. Bakke, A. Vader, O. Olsvik, and M.R. El-Gewely Isolation of cmr, a novel Escherichia coli chloramphenicol resistance gene encoding a putative efflux pump J. Bacteriol. 178 1996 3188 3193
59. C. Bohn, and P. Bouloc The Escherichia coli cmlA gene encodes the multidrug efflux pump Cmr/MdfA and is responsible for isopropyl-beta-d- thiogalactopyranoside exclusion and spectinomycin sensitivity J. Bacteriol. 180 1998 6072 6075
60. R. Edgar, and E. Bibi MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition J. Bacteriol. 179 1997 2274 2280
61. N. Kobayashi, K. Nishino, and A. Yamaguchi Novel macrolide-specific ABC-type efflux transporter in Escherichia coli J. Bacteriol. 183 2001 5639 5644
62. S. Phadtare, K. Yamanaka, I. Kato, and M. Inouye Antibacterial activity of 4,5-dihydroxy-2-cyclopentan-1-one (DHCP) and cloning of a gene conferring DHCP resistance in Escherichia coli J. Mol. Microbiol. Biotechnol. 3 2001 461 465
63. S.M. Wigfield, G.P. Rigg, M. Kavari, A.K. Webb, R.C. Matthews, and J.P. Burnie Identification of an immunodominant drug efflux pump in Burkholderia cepacia J. Antimicrob. Chemother. 49 2002 619 624
64. C.C. Miyamae, and M.A. Valvano Cloning and characterization of the Burkholderia vietnamensis norM gene encoding a multi-drug efflux system FEMS Microbiol. Lett. 215 2002 279 283
65. M.N. Huda, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya Na+-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium FEMS Microbiol. Lett. 203 2001 235 239
66. K. Nishino, and A. Yamaguchi Analysis of a complete library of putative drug transporter genes in Escherichia coli J. Bacteriol. 183 2001 5803 5812
67. M.C. Sulavik, C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene, B. DiDomenico, K.J. Shaw, G.H. Miller, R. Hare, and G. Shimer Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes Antimicrob. Agents Chemother. 45 2001 1126 1136
68. E.Y. Rosenberg, D. Ma, and H. Nikaido AcrD of Escherichia coli is an aminoglycoside efflux pump J. Bacteriol. 182 2000 1754 1756
69. C. Elkins, and H. Nikaido Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops J. Bacteriol. 184 2002 6490 6498
70. A.S. Jellen-Ritter, and W.V. Kern Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone Antimicrob. Agents Chemother. 45 2001 1467 1472
71. K. Kobayashi, N. Tsukagoshi, and R. Aono Suppression of hypersensitivity of Escherichia coli acrB mutant to organic solvents by integrational activation of the acrEF operon with the IS1 or IS2 element J. Bacteriol. 183 2001 2646 2653
72. N. Baranova, and H. Nikaido The BaeSR two-component regulatory system activates transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and increases its resistance to novobiocin and deoxycholate J. Bacteriol. 184 2002 4168 4176
73. S. Nagakubo, K. Nishino, T. Hirata, and A. Yamaguchi The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC J. Bacteriol. 184 2002 4161 4167
74. K. Poole, N. Gotoh, H. Tsujimoto, Q. Zhao, A. Wada, T. Yamasaki, S. Neshat, J. Yamagishi, X.Z. Li, and T. Nishino Overexpression of the mexC-mexD-oprJ effux operon in nfxB-type multidrug resistant strains Mol. Microbiol. 21 1996 713 724
75. T. Kohler, M. Michea-Hamzehpour, U. Henze, N. Gotoh, L.K. Curty, and J.C. Pechere Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa Mol. Microbiol. 23 1997 345 354
76. T. Mine, Y. Morita, A. Kataoka, T. Mizushima, and T. Tsuchiya Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa Antimicrob. Agents Chemother. 43 1999 415 417
77. R. Chuanchuen, C.T. Narasaki, and H.P. Schweizer The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan J. Bacteriol. 184 2002 5036 5044
78. S. Aendekerk, B. Ghysels, P. Cornelis, and C. Baysse Characterization of a new efflux pump, MexGHI-OpmD, from Pseudomonas aeruginosa that confers resistance to vanadium Microbiology 148 2002 2371 2381
79. Y. Li, T. Mima, Y. Komori, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa J. Antimicrob. Chemother. 52 2003 572 575
80. J. Jo, F.S.L. Brinkman, and R.E.W. Hancock Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins Antimicrob. Agents Chemother. 47 2003 1101 1111
81. X.Z. Li, D. Ma, D.M. Livermore, and H. Nikaido Role efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to b-lactam resistance Antimicrob. Agents Chemother. 38 1994 1742 1752
82. X.Z. Li, H. Nikaido, and K. Poole Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 39 1995 1948 1953
83. X.-Z. Li, R. Srikumar, and K. Poole b-Lactamase inhibitors are substrates for the multidrug efflux pumps of Pseudmonas aeruginosa Antimicrob. Agents Chemother. 42 1998 399 403
84. T. Kohler, M. Kok, M. Michea-Hamzehpour, P. Plesiat, N. Gotoh, K. Nishino, L.K. Curty, and J.C. Pechere Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 40 1996 2288 2290
85. H.P. Schweizer Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems Antimicrob. Agents Chemother. 42 1998 394 398
86. X.Z. Li, L. Zhang, and K. Poole Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance J. Bacteriol. 180 1998 2987 2991
87. R. Srikumar, T. Kon, N. Gotoh, and K. Poole Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain Antimicrob. Agents Chemother. 42 1998 65 71
88. N. Masuda, N. Gotoh, C. Ishi, E. Sakagawa, S. Ohya, and T. Nishino Interplay between chromosomal b-lactamase and the MexAB-OprM efflux system in intrinsic resistance to β-lactams in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 43 1999 400 402
89. T. Nakae, A. Nakajima, T. Ono, K. Saito, and H. Yoneyama Resistance to beta-lactam antibiotics in Pseudomonas aeruginosa due to interplay between the MexAB-OprM efflux pump and beta-lactamase Antimicrob. Agents Chemother. 43 1999 1301 1303
90. R.J. Williams, D.M. Livermore, M.A. Lindridge, A.A. Said, and J.D. Williams Mechanisms of beta-lactam resistance in british isolates of Pseudomonas aeruginosa J. Med. Microbiol. 17 1984 283 293
91. F. Bert, and N. Lambert-Zechovsky Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards J. Antimicrob. Chemother. 37 1996 809 813
92. K.L. Beinlich, R. Chuanchuen, and H.P. Schweizer Contribution of multidrug efflux pumps to muliple antibiotic resistance in veterinary clinical isolates of Pseudomonas aeruginosa FEMS Microbiol. Lett. 198 2001 129 134
93. K. Saito, H. Yoneyama, and T. Nakae nalB-type mutations cuasing the overexpression of the MexAB-OprM efflux pump are located in the mexR gene of the Pseudomonas aeruginosa chromosome FEMS Microbiol. Lett. 179 1999 67 72
94. P.G. Higgins, A.C. Fluit, D. Milatovic, J. Verhoef, and F.J. Schmitz Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa Int. J. Antimicrob. Agents 21 2003 409 413
95. I. Ziha Zafiri, C. Llanes, T. Kohler, J.-C. Pechere, and P. Plesiat In vivo emergence of multidrug resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM Antimicrob. Agents Chemother. 43 1999 287 291
96. L. Cao, R. Srikumar, and K. Poole MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719 Mol. Microbiol. 53 2004 1423 1436
97. R. Chuanchuen, K. Beinlich, T.T. Hoang, A. Becher, R.R. Karkhoff-Schweizer, and H.P. Schweizer Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ Antimicrob. Agents Chemother. 45 2001 428 432
98. N. Masuda, N. Gotoh, S. Ohya, and T. Nishino Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa Antimicrob. Agents Chemother. 40 1996 909 913
99. X.Z. Li, N. Barre, and K. Poole Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa J. Antimicrob. Chemother. 46 2000 885 893
100. N. Masuda, E. Sakagawa, S. Ohya, N. Gotoh, and K. Nishino Hypersusceptibility of the Pseudomonas aeruginosa nfxB mutant to β-lactams due to reduced expression of the AmpC β-lactamase Antimicrob. Agents Chemother. 45 2001 1284 1286
101. O.F. Join-Lambert, M. Michea-Hamzehpour, T. Kohler, F. Chau, F. Faurisson, S. Dautrey, C. Vissuzaine, C. Carbon, and J. Pechere Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats Antimicrob. Agents Chemother. 45 2001 571 576
102. Y. Morita, Y. Komori, T. Mima, T. Kuroda, T. Mizushima, and T. Tsuchiya Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump FEMS Microbiol. Lett. 202 2001 139 143
103. Y. Morita, T. Murata, T. Mima, S. Shiota, T. Kuroda, T. Mizushima, N. Gotoh, T. Nishino, and T. Tsuchiya Induction of mexCD-oprN operon for a multidrug efflux pump by disinfectants in wild-type Pseudomonas aeruginosa PAO1 J. Antimicrob. Chemother. 51 2003 991 994
104. M.M. Ochs, M.P. McCusker, M. Bains, and R.E. Hancock Negative regulation of the Pseudomonas aeruginosa outer membrane porin OprD selective for imipenem and basic amino acids Antimicrob. Agents Chemother. 43 1999 1085 1090
105. N. Masuda, E. Sakagawa, and S. Ohya Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 39 1995 645 649
106. H. Fukuda, M. Hosaka, K. Hirai, and S. Iyobe New norfloxacin resistance gene in Pseudomonas aeruginosa PAO Antimicrob. Agents Chemother. 34 1990 1757 1761
107. T. Kohler, M. Michea-Hamzehpour, P. Plesiat, A.L. Kahr, and J.C. Pechere Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 41 1997 2540 2543
108. J.R. Aires, T. Kohler, H. Nikaido, and P. Plesiat Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides Antimicrob. Agents Chemother. 43 1999 2624 2628
109. N. Masuda, E. Sagagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa Antimicrob. Agents Chemother. 44 2000 2242 2246
110. S. Westbrock-Wadman, D.R. Sherman, M.J. Hickey, S.N. Coulter, Y.Q. Zhu, P. Warrener, L.Y. Nguyen, R.M. Shawar, K.R. Folger, and C.K. Stover Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability Antimicrob. Agents Chemother. 43 1999 2975 2983
111. M.L. Sobel, G.A. McKay, and K. Poole Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates Antimicrob. Agents Chemother. 47 2003 3202 3207
112. C. Vogne, J.R. Aires, C. Bailly, D. Hocquet, and P. Plesiat Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis Antimicrob. Agents Chemother. 48 2004 1676 1680
113. H. Sekiya, T. Mima, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya Functional cloning and characterization of a multidrug efflux pump, mexHI-opmD, from a Pseudomonas aeruginosa mutant Antimicrob. Agents Chemother. 47 2003 2990 2992
114. J.R.W. Govan, and V. Deretic Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia Microbiol. Rev. 60 1996 539 574
115. J.L. Burns, C.D. Wadsworth, J.J. Barry, and C.P. Goodall Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance Antimicrob. Agents Chemother. 40 1996 307 313
116. L. Zhang, X.Z. Li, and K. Poole Fluoroquinolone susceptibilities of efflux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia J. Antimicrob. Chemother. 48 2001 549 552
117. D.A.B. Dance Meliodosis: the tip of the iceberg? Clin. Microbiol. Rev. 4 1991 52 60
118. A.J. Simpson, N.J. White, and V. Wuthiekanun Aminoglycoside and macrolide resistance in Bukholderia pseudomallei Antimicrob. Agents Chemother. 43 1999 2332
119. R.A. Moore, D. DeShazer, S. Reckseidler, A. Weissman, and D.E. Woods Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei Antimicrob. Agents Chemother. 43 1999 465 470
120. Y.Y. Chan, T.M.C. Tan, Y.M. Ong, and K.L. Chua BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei Antimicrob. Agents Chemother. 48 2004 1128 1135
121. M. Denton, and K.G. Kerr Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia Clin. Microbiol. Rev. 11 1998 57 80
122. X.-Z. Li, L. Zhang, and K. Poole SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia Antimicrob. Agents Chemother. 46 2002 333 343
123. A. Alonso, and J.L. Martinez Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia Antimicrob. Agents Chemother. 44 2000 3079 3086
124. A. Alonso, and J.L. Martinez Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia Antimicrob. Agents Chemother. 45 2001 1879 1881
125. K.E. Hagman, W. Pan, B.G. Spratt, J.T. Balthazar, R.C. Judd, and W.M. Shafer Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system Microbiology 141 1995 611 622
126. L. Zarantonelli, G. Borthagaray, E.H. Lee, W. Veal, and W.M. Shafer Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae J. Antimicrob. Chemother. 47 2001 651 654
127. A. Hejazi, and F.R. Falkiner Serratia marcescens J. Med. Microbiol. 46 1997 903 912
128. A. Kumar, and E. Worobec S.G. Pandalai Recent Res. Devel. Microbiol. vol. 7 2003 307 324
129. A. Kumar, and E.A. Worobec Cloning, sequencing and characterization of the SdeAB efflux pump of Serratia marcescens Antimicrob. Agents Chemother. 49 2005 1495 1501
130. J. Chen, T. Kuroda, M.N. Huda, T. Mizushima, and T. Tsuchiya An RND-type multidrug efflux pump SdeXY from Serratia marcescens J. Antimicrob. Chemother. 52 2003 176 179
131. E. Bergogne-Berezin, and K.J. Towner Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features Clin. Microbiol. Rev. 9 1996 148 165
132. S. Magnet, P. Courvalin, and T. Lambert Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 Antimicrob. Agents Chemother. 45 2001 3375 3380
133. S.L. Chau, Y.W. Chu, and E.T. Houang Novel resistance-nodulation-cell division efflux system AdeDE in Acinetobacter genomic DNA group 3 Antimicrob. Agents Chemother. 48 2004 4054 4055
134. C.E. Cherubin, and R.H. Eng Quinolones for the treatment of infections due to Salmonella Rev. Infect. Dis. 13 1991 343 344
135. E. Giraud, A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium Antimicrob. Agents Chemother. 44 2000 1223 1228
136. A. Olliver, M. Valle, E. Chaslus-Dancla, and A. Cloeckaert Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 and IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones Antimicrob. Agents Chemother. 49 2005 289 301
137. D.J. Eaves, V. Ricci, and L.J. Piddock Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance Antimicrob. Agents Chemother. 48 2004 1145 1150
138. E. Pradel, and J.M. Pages The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes Antimicrob. Agents Chemother. 46 2002 2640 2643
139. A. Mazzariol, J. Zuliani, G. Cornaglia, G.M. Rossolini, and R. Fontana AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob. Agents Chemother. 46 2002 3984 3986
140. B.M. Allos Campylobacter jejuni Infections: update on emerging issues and trends Clin. Infect. Dis. 32 2001 1201 1206
141. J. Lin, L.O. Michel, and Q. Zhang CmeABC functions as a multidrug efflux system in Campylobacter jejuni Antimicrob. Agents Chemother. 46 2002 2124 2131
142. V. Koronakis, A. Sharff, E. Koronakis, B. Luisi, and C. Hughes Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export Nature 405 2000 914 919
143. S. Murakami, R. Nakashima, E. Yamashita, and A. Yamaguchi Crystal structure of bacterial multidrug efflux transporter AcrB Nature 419 2002 587 593
144. M.K. Higgins, E. Bokma, E. Koronakis, C. Hughes, and V. Koronakis Structure of the periplasmic component of a bacterial drug efflux pump Proc. Natl. Acad. Sci. U. S. A. 101 2004 9994 9999
145. H. Akama, T. Matsuura, S. Kashiwagi, H. Yoneyama, S.-I. Narita, T. Tsukihara, A. Nakagawa, and T. Nakae Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa J. Biol. Chem. 279 2004 25939 25942
146. J. Eswaran, E. Koronakis, M.K. Higgins, C. Hughes, and V. Koronakis Three's company: component structures bring a closer view of tripartite drug efflux pumps Curr. Opin. Struct. Biol. 14 2004 741 747
147. C. Andersen, E. Koronakis, E. Bokma, J. Eswaran, D. Humphreys, C. Hughes, and V. Koronakis Transition to the open state of the TolC periplasmic tunnel entrance Proc. Natl. Acad. Sci. U. S. A. 99 2002 11103 11108
148. H.I. Zgurskaya, and H. Nikaido Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 96 1999 7190 7195
149. W. Mao, M.S. Warren, D.S. Black, T. Satou, T. Murata, T. Nishino, N. Gotoh, and O. Lomovskaya On the mechanism of substrate specificity by resistance nodulation division (RND)-type multidrug resistance pumps: the large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition Mol. Microbiol. 46 2002 889 901
150. C.A. Elkins, and H. Nikaido Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops J. Bacteriol. 184 2002 6490 6498
151. E.B. Tikhonova, Q. Wang, and H.I. Zgurskaya Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria J. Bacteriol. 184 2002 6499 6507
152. S. Eda, H. Maseda, and T. Nakae An elegant means of self-protection in gram-negative bacteria by recognizing and extruding xenobiotics from the periplasmic space J. Biol. Chem. 278 2003 2085 2088
153. E.W. Yu, J.R. Aires, and H. Nikaido AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity J. Bacteriol. 185 2003 5657 5664
154. E.W. Yu, G. McDermott, H.I. Zgurskaya, H. Nikaido, and D.E. Koshland Jr. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump Science 300 2003 976 980
155. H.I. Zgurskaya, and H. Nikaido AcrA is a highly asymmetric protein capable of spanning the periplasm J. Mol. Biol. 285 1999 409 420
156. T. Thanabalu, E. Koronakis, C. Hughes, and V. Koronakis Substrate-induced assembly of a contiguous channel for protein export from E. coli: reversible bridging of an inner-membrane translocase to an outer membrane exit pore EMBO J. 17 1998 6487 6496
157. T. Touze, J. Eswaran, E. Bokma, E. Koronakis, C. Hughes, and V. Koronakis Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system Mol. Microbiol. 53 2004 697 706
158. C.K. Stover, X.-Q. Pham, A.L. Erwin, S.D. Mizoguchi, P. Warrener, M.J. Hickey, F.S.L. Brinkman, W.O. Hufnagle, D.J. Kowalik, M. Lagrou, R.L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L.L. Brody, S.N. Coulter, K.R. Folger, A. Kas, K. Larbig, R. Lim, D. Spencer, G.K.-S. Wong, Z. Wu, I.T. Paulsen, J. Reizer, M.H. Saier, R.E.W. Hancock, S. Lory, and M.V. Olson Complete genome sequence of Pseudomonas aeruginosa, an opportunistic pathogen Nature 406 2000 959 964
159. D.G. Thanassi, L.W. Cheng, and H. Nikaido Active efflux of bile salts by Escherichia coli J. Bacteriol. 179 1997 2512 2518
160. W.M. Shafer, J.T. Balthazar, K.E. Hagman, and S.A. Morse Missense mutations that alter the DNA-binding domain of the MtrR protein that occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to fecal lipids Microbiology 141 1995 907 911
161. R.B. Helling, B.K. Janes, H. Kimball, T. Tran, M. Bundesmann, P. Check, D. Phelan, and C. Miller Toxic waste disposal in Escherichia coli J. Bacteriol. 184 2002 3699 3703
162. S. Rahmati, S. Yang, A.L. Davidson, and E.L. Zechiedrich Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA Mol. Microbiol. 43 2002 677 685
163. E.C. Pesci, J.B.J. Milbank, J.P. Pearson, S. McKnight, A.S. Kende, E.P. Greenberg, and B.H. Iglewski Quinolone signalling in the cell-to-cell cummunication system of Pseudomonas aeruginosa Proc. Natl. Acad. Sci. U. S. A. 96 1999 11229 11234
164. T. Kohler, C. van Delden, L. Kocjanic Curty, M.M. Hamzehpour, and J.-C. Pechere Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa J. Bacteriol. 183 2001 5213 5222
165. Y. Hirakata, R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, R.E. Hancock, and D.P. Speert Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeruginosa J. Exp. Med. 196 2002 109 118
166. 2+ channels in the membrane Biochim. Biophys. Acta 1612 2003 90 97
167. P. Orth, D. Schnappinger, W. Hillen, W. Saenger, and W. Hinrichs Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system Nat. Struct. Biol. 7 2000 215 219
168. H. Wang, J.L. Dzink-Fox, M. Chen, and S.B. Levy Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations Antimicrob. Agents Chemother. 45 2001 1515 1521
169. D. Ma, D.N. Cook, J.E. Hearst, and H. Nikaido Efflux pumps and drug resistance in Gram-negative bacteria Trends Microbiol. 2 1994 489 493
170. L. Zhang, X.-Z. Li, and K. Poole SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia Antimicrob. Agents Chemother. 45 2001 3497 3503
171. K. Evans, L. Adewoye, and K. Poole MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region J. Bacteriol. 183 2001 807 812
172. L. Adewoye, A. Sutherland, R. Srikumar, and K. Poole The MexR repressor of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: characterization of mutants compromising activity J. Bacteriol. 184 2002 4308 4312
173. S. Jalal, O. Ciofu, N. Hoiby, N. Gotoh, and B. Wretlind Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients Antimicrob. Agents Chemother. 44 2000 710 712
174. T. Kohler, S.F. Epp, L.K. Curty, and J.C. Pechere Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa J. Bacteriol. 181 1999 6300 6305
175. H. Maseda, K. Saito, A. Nakajima, and T. Nakae Variation of the mexT gene, a regulator of the MexEF-OprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa FEMS Microbiol. Lett. 192 2000 107 112
176. K. Nishino, and A. Yamaguchi EvgA of the two-component signal transduction system modulates production of the YhiUV multidrug transporter in Escherichia coli J. Bacteriol. 184 2002 2319 2323
177. Y. Eguchi, T. Oshima, H. Mori, R. Aono, K. Yamamoto, A. Ishihama, and R. Utsumi Transcriptional regulation of drug effux genes by EvgAS, a two-component system in Escherichia coli Microbiology 149 2003 2819 2828
178. K. Perron, O. Caille, C. Rossier, C. van Delden, J.-L. Dumas, and T. Kohler CzcR-CzcS, a two-component system involved in heavy metal and carbapenem resistance in Pseudomonas aeruginosa J. Biol. Chem. 279 2004 8761 8768
179. M.N. Alekshun, and S.B. Levy Regulation of chromosomally mediated multiple antibiotic resistance: the mar operons Antimicrob. Agents Chemother. 41 1997 2067 2075
180. N. Delihas, and S. Forst micF: an antisense RNA gene involved in response of Escherichia coli to global stress factors J. Mol. Biol. 313 2001 1 12
181. R. Chollet, C. Bollet, J. Chevalier, M. Mallea, J.M. Pages, and A. Davin-Regli mar Operon involved in multidrug resistance of Enterobacter aerogenes Antimicrob. Agents Chemother. 46 2002 1093 1097
182. D.G. White, J.D. Goldman, B. Demple, and S.B. Levy Role of the acrAB locus in organic solvent tolerance mediated by expression fo marA, soxS, or robA in Escherichia coli J. Bacteriol. 179 1997 6122 6126
183. T. Nunoshiba, E. Hidalgo, C.F. Amabile Cuevas, and B. Demple Two-stage control of an oxidative stress regulon: the Escherichia coli SoxR protein tiggers redox-inducible expression of the soxS regulatory gene J. Bacteriol. 174 1992 6054 6060
184. R.G. Martin, and J.L. Rosner Fis, an accessorial factor for transcriptional activation of the mar (multiple antibiotic resistance) promoter of Escherichia coli in the presence of the activator MarA, SoxS, or Rob J. Bacteriol. 179 1997 7410 7419
185. E.Y. Rosenberg, D. Bertenthal, M.L. Nilles, K.P. Bertrand, and H. Nikaido Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein Mol. Microbiol. 48 2003 1609 1619
186. S. Yaron, D.G. White, and K.R. Matthews Characterization of an Escherichia coli O157:H7 marR mutant Int. J. Food Microbiol. 85 2003 281 291
187. M.M. Tavio, J. Vila, M. Perilli, L.T. Casanas, L. Macia, G. Amicosante, and M.T. Jimenez de Anta Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains J. Med. Microbiol. 53 2004 1119 1122
188. A.M. George, R.M. Hall, and H.W. Stokes Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli Microbiology 141 1995 1909 1920
189. A. Ruzin, M.A. Visalli, D. Keeney, and P.A. Bradford Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae Antimicrob. Agents Chemother. 49 2005 1017 1022
190. M.A. Yassein, H.E. Ewis, C.-D. Lu, and A.T. Abdelal Molecular cloning and characterization of the Salmonella enterica serovar Paratyphi B rma gene, which confers multiple drug resistance in Escherichia coli Antimicrob. Agents Chemother. 44 2002 10 13
191. R. Chollet, J. Chevalier, C. Bollet, J.M. Pages, and A. Davin-Regli RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes Antimicrob. Agents Chemother. 48 2004 2518 2523
192. C. Llanes, D. Hocquet, C. Vogne, D. Benali-Baitich, C. Neuwirth, and P. Plesiat Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously Antimicrob. Agents Chemother. 48 2004 1797 1802
193. R. Srikumar, and P.C.J.K. Poole Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa J. Bacteriol. 182 2000 1410 1414
194. O. Lomovskaya, and W.J. Watkins Efflux pumps: their role in antibacterial drug discovery Curr. Med. Chem. 8 2001 1699 1711
195. O. Lomovskaya, and W. Watkins Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria J. Mol. Microbiol. Biotechnol. 3 2001 225 236
196. O. Lomovskaya, M.S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V.J. Lee Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy Antimicrob. Agents Chemother. 45 2001 105 116
197. T.E. Renau, R. Leger, E.M. Flamme, J. Sangalang, M.W. She, R. Yen, C.L. Gannon, D. Griffith, S. Chamberland, O. Lomovskaya, S.J. Hecker, V.J. Lee, T. Ohta, and K. Nakayama Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin J. Med. Chem. 42 1999 4928 4931
198. T.E. Renau, R. Leger, E.M. Flamme, M.W. She, C.L. Gannon, K.M. Mathias, O. Lomovskaya, S. Chamberland, V.J. Lee, T. Ohta, K. Nakayama, and Y. Ishida Addressing the stability of C-capped dipeptide efflux pump inhibitors that potentiate the activity of levofloxacin in Pseudomonas aeruginosa Bioorg. Med. Chem. Lett. 11 2001 663 667
199. D. Griffith, O. Lomovskaya, and V. Lee Abstract presented at the 39th Interscience Conference on Antimicrobials Agents and Chemotherapy, San Francisco, CA 1999
200. M. Mallea, J. Chevalier, A. Eyraud, and J.M. Pages Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains Biochem. Biophys. Res. Commun. 293 2002 1370 1373
201. L. Mamelli, J.P. Amoros, J.M. Pages, and J.M. Bolla A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides Int. J. Antimicrob. Agents 22 2003 237 241
202. M.D. Lee, J.L. Galazzo, A.L. Staley, J.C. Lee, M.S. Warren, H. Fuernkranz, S. Chamberland, O. Lomovskaya, and G.H. Miller Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance Farmaco 56 2001 81 85
203. J. Chevalier, J. Bredin, A. Mahamoud, M. Mallea, J. Barbe, and J.M. Pages Inhibitors of antibiotic efflux in resistant Enterobacter aerogenes and Klebsiella pneumoniae strains Antimicrob. Agents Chemother. 48 2004 1043 1046
204. M.L. Nelson, and S.B. Levy Reversal of tetracycline resistance mediated by different bacterial tetracycline resistance determinants by an inhibitor of the Tet(B) antiport protein Antimicrob. Agents Chemother. 43 1999 1719 1724
205. F.R. Stermitz, P. Lorenz, J.N. Tawara, L.A. Zenewicz, and K. Lewis Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proc. Natl. Acad. Sci. U. S. A. 2000 1433 1437
206. G. Tegos, F.R. Stermitz, O. Lomovskaya, and K. Lewis Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials Antimicrob. Agents Chemother. 46 2002 3133 3141
207. N.R. Guz, F.R. Stermitz, J.B. Johnson, T.D. Beeson, S. Willen, J. Hsiang, and K. Lewis Flovaonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure activity relationship J. Med. Chem. 44 2001 261 268
208. H. Fukuda, S. Hori, and K. Hiramatsu Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus Antimicrob. Agents Chemother. 42 1998 1917 1922
209. T.D. Gootz, R.P. Zaniewski, S.L. Haskell, F.S. Kaczmarek, and A.E. Maurice Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus Antimicrob. Agents Chemother. 43 1999 1845 1855
210. + antiporter Antimicrob. Agents Chemother. 39 1995 247 249
211. C.R. Dean, M.A. Visalli, S.J. Projan, P.E. Sum, and P.A. Bradford Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1 Antimicrob. Agents Chemother. 47 2003 972 978
212. M.A. Visalli, E. Murphy, S.J. Projan, and P.A. Bradford AcraAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis Antimicrob. Agents Chemother. 47 2003 665 669
213. A. Ruzin, D. Keeney, and P.A. Bradford AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii Antimicrob. Agents Chemother. 49 2005 791 793
214. R.E.W. Hancock, and F.S. Brinkman Function of Pseudomonas porins in uptake and efflux Annu. Rev. Microbiol. 56 2002 17 38
215. H. Labischinski, G. Barnickel, H. Bradaczek, D. Naumann, E.T. Rietschel, and P. Giesbrecht High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane J. Bacteriol. 162 1985 9 20
216. A. Wiese, K. Brandenburg, A.J. Ulmer, U. Seydel, and S. Muller-Loennies The dual role of lipopolysaccharide as effector and target molecule Biol. Chem. 380 1999 767 784
217. I. Sadovskaya, J.R. Brisson, J.S. Lam, J.C. Richards, and E. Altman Structural elucidation of the lipopolysaccharide core regions of the wild-type strain PAO1 and O-chain-deficient mutant strains AK1401 and AK1012 from Pseudomonas aeruginosa serotype O5 Eur. J. Biochem. 255 1998 673 684
218. M. Vaara Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria Antimicrob. Agents Chemother. 37 1993 354 356
219. P. Plesiat, J.R. Aires, C. Godard, and T. Kohler Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa J. Bacteriol. 179 1997 7004 7010
220. J. Nesper, C.M. Lauriano, K.E. Klose, D. Kapfhammer, A. Kraiss, and J. Reidl Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation Infect. Immun. 69 2001 435 445
221. I. Moriyon, and I. Lopez-Goni Structure and properties of the outer membranes of Brucella abortus and Brucella melitensis Int. Microbiol. 1 1998 19 26
222. J. Velasco, J.A. Bengoechea, K. Brandenburg, B. Lindner, U. Seydel, D. Gonzalez, U. Zahringer, E. Moreno, and I. Moriyon Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance Infect. Immun. 68 2000 3210 3218
223. J.A. Bengoechea, B. Lindner, U. Seydel, R. Diaz, and I. Moriyon Yersinia pseudotuberculosis and Yersinia pestis are more resistant to bactericidal cationic peptides than Yersinia enterocolitica Microbiology 144 1998 1509 1515
224. J.A. Bengoechea, K. Brandenburg, U. Seydel, R. Diaz, and I. Moriyon Yersinia pseudotuberculosis and Yersinia pestis show increased outer membrane permeability to hydrophobic agents which correlates with lipopolysaccharide acyl-chain fluidity Microbiology 144 1998 1517 1526
225. M.N. Burtnick, and D.E. Woods Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance Antimicrob. Agents Chemother. 43 1999 2648 2656
226. W. Kaca, J. Radziejewska-Lebrecht, and U.R. Bhat Effect of polymyxins on the lipopolysaccharide-defective mutants of Proteus mirabilis Microbios 61 1990 23 32
227. 31P-NMR study Mol. Microbiol. 11 1994 481 487
228. K. Nummila, I. Kilpelainen, U. Zahringer, M. Vaara, and I.M. Helander Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A Mol. Microbiol. 16 1995 271 278
229. F. Yoshimura, and H. Nikaido Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12 Antimicrob. Agents Chemother. 27 1985 84 92
230. H. Nikaido, and E.Y. Rosenberg Effect on solute size on diffusion rates through the transmembrane pores of the outer membrane of Escherichia coli J. Gen. Physiol. 77 1981 121 135
231. F.W. Goldstein, L. Gutmann, R. Williamson, E. Collatz, and J.F. Acar In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens Ann. Microbiol. (Paris) 134A 1983 329 337
232. K.J. Harder, H. Nikaido, and M. Matsuhashi Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin Antimicrob. Agents Chemother. 20 1981 549 552
233. V. Werner, C.C. Sanders, W.E. Sanders Jr., and R.V. Goering Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae Antimicrob. Agents Chemother. 27 1985 455 459
234. A.A. Medeiros, T.F. O'Brien, E.Y. Rosenberg, and H. Nikaido Loss of OmpC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy J. Infect. Dis. 156 1987 751 757
235. C.S. Toro, S.R. Lobos, I. Calderon, M. Rodriguez, and G.C. Mora Clinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol Antimicrob. Agents Chemother. 34 1990 1715 1719
236. J.L. Burns, and A.L. Smith A major outer-membrane protein functions as a porin in Haemophilus influenzae J. Gen. Microbiol. 133 Pt 5 1987 1273 1277
237. B. Pangon, C. Bizet, A. Bure, F. Pichon, A. Philippon, B. Regnier, and L. Gutmann In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase J. Infect. Dis. 159 1989 1005 1006
238. M. Mallea, J. Chevalier, C. Bornet, A. Eyraud, A. Davin-Regli, C. Bollet, and J.M. Pages Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes Microbiology 144 1998 3003 3009
239. J.W. Chow, and D.M. Shlaes Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes J. Antimicrob. Chemother. 28 1991 499 504
240. C. Bornet, A. Davin-Regli, C. Bosi, J.M. Pages, and C. Bollet Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability J. Clin. Microbiol. 38 2000 1048 1052
241. J. Chevalier, J.M. Pages, and M. Mallea In vivo modification of porin activity conferring antibiotic resistance to Enterobacter aerogenes Biochem. Biophys. Res. Commun. 266 1999 248 251
242. E. De, A. Basle, M. Jaquinod, N. Saint, M. Mallea, G. Molle, and J.M. Pages A new mechanism of antibiotic resistance in Enterobacteriaceae induced by a structural modification of the major porin Mol. Microbiol. 41 2001 189 198
243. G. Cornaglia, A. Mazzariol, R. Fontana, and G. Satta Diffusion of carbapenems through the outer membrane of enterobacteriaceae and correlation of their activities with their periplasmic concentrations Microb. Drug Resist. 2 1996 273 276
244. V.T. Cao, G. Arlet, B.M. Ericsson, A. Tammelin, P. Courvalin, and T. Lambert Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration J. Antimicrob. Chemother. 46 2000 895 900
245. S. Hernandez-Alles, M. Conejo, A. Pascual, J.M. Tomas, V.J. Benedi, and L. Martinez-Martinez Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae J. Antimicrob. Chemother. 46 2000 273 277
246. M.J. Gill, S. Simjee, K. Al-Hattawi, B.D. Robertson, C.S. Easmon, and C.A. Ison Gonococcal resistance to beta-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus Antimicrob. Agents Chemother. 42 1998 2799 2803
247. H. Nikaido, and R.E. Hancock J.R. Sokatch The Bacteria: A Treatise on Structure and Function 1986 Academic Press London 145 193
248. W.A. Woodruff, and R.E. Hancock Construction and characterization of Pseudomonas aeruginosa protein F-deficient mutants after in vitro and in vivo insertion mutagenesis of the cloned gene J. Bacteriol. 170 1988 2592 2598
249. L. Pumbwe, M.J. Everett, R.E. Hancock, and L.J. Piddock Role of gyrA mutation and loss of OprF in the multiple antibiotic resistance phenotype of Pseudomonas aeruginosa G49 FEMS Microbiol. Lett. 143 1996 25 28
250. J.P. Quinn, E.J. Dudek, C.A. DiVincenzo, D.A. Lucks, and S.A. Lerner Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections J. Infect. Dis. 154 1986 289 294
251. L. Martinez-Martinez, A. Pascual, M.C. Conejo, L. Picabea, and E.J. Perea Resistance of Pseudomonas aeruginosa to imipenem induced by eluates from siliconized latex urinary catheters is related to outer membrane protein alterations Antimicrob. Agents Chemother. 43 1999 397 399
252. J.P. Pirnay, D. De Vos, D. Mossialos, A. Vanderkelen, P. Cornelis, and M. Zizi Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates Environ. Microbiol. 4 2002 872 882
253. D.J. Wolter, N.D. Hanson, and P.D. Lister Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance FEMS Microbiol. Lett. 236 2004 137 143
254. Y. Yamano, T. Nishikawa, and Y. Komatsu Outer membrane proteins responsible for the penetration of beta-lactams and quinolones in Pseudomonas aeruginosa J. Antimicrob. Chemother. 26 1990 175 184
255. A. Tabata, H. Nagamune, T. Maeda, K. Murakami, Y. Miyake, and H. Kourai Correlation between resistance of Pseudomonas aeruginosa to quaternary ammonium compounds and expression of outer membrane protein OprR Antimicrob. Agents Chemother. 47 2003 2093 2099
256. R.E. Hancock Alterations in outer membrane permeability Annu. Rev. Microbiol. 38 1984 237 264
257. S. Sukupolvi, and M. Vaara Salmonella typhimurium and Escherichia coli mutants with increased outer membrane permeability to hydrophobic compounds Biochim. Biophys. Acta 988 1989 377 387
258. M. Vaara, and M. Nurminen Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis Antimicrob. Agents Chemother. 43 1999 1459 1462
259. R.E. Hancock The bacterial outer membrane as a drug barrier Trends Microbiol. 5 1997 37 42
260. R.E. Hancock Antibacterial peptides and the outer membranes of gram-negative bacilli J. Med. Microbiol. 46 1997 1 3
261. H.M. Ayres, D.N. Payne, J.R. Furr, and A.D. Russell Effect of permeabilizing agents on antibacterial activity against a simple Pseudomonas aeruginosa biofilm Lett. Appl. Microbiol. 27 1998 79 82
262. R.M. Epand, and H.J. Vogel Diversity of antimicrobial peptides and their mechanisms of action Biochim. Biophys. Acta 1462 1999 11 28
263. M. Vaara Agents that increase the permeability of the outer membrane Microbiol. Rev. 56 1992 395 411
264. M. Vaara, and M. Porro Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria Antimicrob. Agents Chemother. 40 1996 1801 1805
265. K. Kikuchi, E.M. Bernard, A. Sadownik, S.L. Regen, and D. Armstrong Antimicrobial activities of squalamine mimics Antimicrob. Agents Chemother. 41 1997 1433 1438
266. A. Giacometti, O. Cirioni, M.S. Del Prete, F. Barchiesi, A.M. Paggi, E. Petrelli, and G. Scalise Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii J. Antimicrob. Chemother. 46 2000 807 810
267. A. Giacometti, O. Cirioni, M.S. Del Prete, A.M. Paggi, M.M. D'Errico, and G. Scalise Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria Peptides 21 2000 1155 1160
268. C. Li, M.R. Lewis, A.B. Gilbert, M.D. Noel, D.H. Scoville, G.W. Allman, and P.B. Savage Antimicrobial activities of amine- and guanidine-functionalized cholic acid derivatives Antimicrob. Agents Chemother. 43 1999 1347 1349
269. X.Z. Li, L. Zhang, and K. Poole Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa J. Antimicrob. Chemother. 45 2000 433 436
270. X.Z. Li, L. Zhang, and H. Nikaido Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis Antimicrob. Agents Chemother. 48 2004 2415 2423
271. X. Li, M. Zolli-Juran, J.D. Cechetto, D.M. Daigle, G.D. Wright, and E.D. Brown Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility Chem. Biol. 11 2004 1423 1430
272. L. Duncan, T. Doyle, Q. Du, J. Ehrhardt, A.S. Lynch, K. Mduli, and G.T. Robertson Construction of a novel Pseudomonas aeruginosa strain panel deficient in fifty-two potential drug efflux systems Abstract presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy Washington, DC 2004
273. W.T. Peng, and E.W. Nester Characterization of a putative RND-type efflux system in Agrobacterium tumefaciens Gene 270 2001 245 252
274. J.D. Palumbo, C.I. Kado, and D.A. Phillips An isoflavonoid-inducible efflux pump in Agrobacterium tumefaciens is involved in competitive colonization of roots J. Bacteriol. 180 1998 3107 3113
275. P. Krummenacher, and F. Narberhaus Two genes encoding a putative multidrug efflux pump of the RND/MFP family are cotranscribed with an rpoH gene in Bradyrhizobium japonicum Gene 241 2000 247 254
276. H.J. Linde, F. Notka, C. Irtenkauf, J. Decker, J. Wild, H.H. Niller, P. Heisig, and N. Lehn Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae J. Antimicrob. Chemother. 49 2002 625 630
277. J.A. Fralick Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli J. Bacteriol. 178 1996 5803 5805
278. C.A. Elkins, and H. Nikaido Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops J. Bacteriol. 184 2002 6490 6498
279. L. Sanchez, W. Pan, M. Vinas, and H. Nikaido The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump J. Bacteriol. 179 1997 6855 6857
280. C.E. Lucas, J.T. Balthazar, K.E. Hagman, and W.M. Shafer The MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae J. Bacteriol. 179 1997 4123 4128
281. E.H. Lee, and W.M. Shafer The farAB-encoded efflux pump mediates resistance of gonococci to long-chained antibacterial fatty acids Mol. Microbiol. 33 1999 839 845
282. T. Ikeda, and F. Yoshimura A resistance-nodulation-cell division family xenobiotic efflux pump in an obligate anaerobe, Porphyromonas gingivalis Antimicrob. Agents Chemother. 46 2002 3257 3260
283. M.A. Visalli, E. Murphy, S.J. Projan, and P.A. Bradford AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis Antimicrob. Agents Chemother. 47 2003 665 669
284. K. Poole, K. Tetro, Q. Zhao, S. Neshat, D. Heinrichs, and N. Bianco Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression Antimicrob. Agents Chemother. 40 1996 2021 2028
285. Y. Li, T. Mima, Y. Komori, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa J. Antimicrob. Chemother. 52 2003 572 575
286. J. Kieboom, J.J. Dennis, J.A. de Bont, and G.J. Zylstra Identification and molecular characterization of an efflux pump involved in Pseudomonas putida S12 solvent tolerance J. Biol. Chem. 273 1998 85 91
287. J.L. Ramos, E. Duque, P. Godoy, and A. Segura Efflux pumps involved in toluene tolerance of Pseudomonas putida DOT-1E J. Bacteriol. 180 1998 3323 3329
288. F. Fukumori, H. Hirayama, H. Takami, A. Inoue, and K. Horikoshi Isolation and transposon mutagenesis of a Pseudomonas putida KT2442 toluene-resistant variant: involvement of an efflux system in solvent resistance Extremophiles 2 1998 395 400
289. G. Mosqueda, and J.L. Ramos A set of genes encoding a second toluene efflux system from Pseudomonas putida DOT-1E is linked to the tod genes for toluene metabolism J. Bacteriol. 182 2000 937 943
290. A. Rojas, E. Duque, G. Mosqueda, G. Golden, A. Hurtado, J.L. Ramos, and A. Segura Three efflux pumps are required to provide efficient tolerance to toluene in Pseudomonas putida DOT-T1E J. Bacteriol. 183 2001 3967 3973
291. H. Nikaido, M. Basina, V. Nguyen, and E.Y. Rosenberg Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those beta-lactam antibiotics containing lipophilic side chains J. Bacteriol. 180 1998 4686 4692
292. F.J. Lacroix, A. Cloeckaert, O. Grepinet, C. Pinault, M.Y. Popoff, H. Waxin, and P. Pardon Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection FEMS Microbiol. Lett. 135 1996 161 167
293. A. Kumar, and E.A. Worobec Fluoroquinolone resistance of Serratia marcescens: involvement of a proton gradient-dependent efflux pump J. Antimicrob. Chemother. 50 2002 593 596